*Department of Pediatrics, Children’s Hospital of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, Pittsburgh, PA
†Sarcoma Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
‡Division of Pediatric Hematology/Oncology, Nationwide Children’s Hospital, The Ohio State University, Columbus, OH
§University of Michigan School of Social Work, Ann Arbor, MI
∥Department of Pediatrics, Section on Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC
¶Quality Department, St Charles Health System, Bend, OR
The authors declare no conflict of interest.
Reprints: Peter H. Shaw, MD, Division of Pediatric Hematology/Oncology, Children’s Hospital of Pittsburgh of UPMC, 4401 Penn Ave., Pittsburgh, PA 15224 (e-mail: [email protected]).
Received August 12, 2014
Accepted January 26, 2015